Market Place
Sourcing Support
Karnataka Launches Online Tracking For Tapentadol Sales
20 Sep 2024 //
PHARMABIZ
Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta
13 Jun 2024 //
GLOBENEWSWIRE
Two painkillers Tapentadol and Pregabalin may go off OTC over misuse
25 Nov 2023 //
ECONOMIC TIMES
Alkem`s Generic Tapentadol Receives Approval in the U.S.
07 Jul 2023 //
FDA
Recall of Palexia® oral solution 20mg/ml and Palexia® 4 mg/ml oral solution
08 Feb 2021 //
PRESS RELEASE
Restrict use of pain reliever Tapentadol: Child rights panel urges government
08 Sep 2020 //
ECONOMIC TIMES
Grünenthal GmbH v. Alkem Labs. Ltd.
28 Mar 2020 //
JDSUPRA
Collegium to acquire U.S. rights to Nucynta from Assertio for $375M
27 Feb 2020 //
BIOWORLD
Palexia SR 100 mg tapentadol sustained release tablets
14 Feb 2020 //
TGA
Collegium Announces Closing of the Nucynta Franchise Acquisition
13 Feb 2020 //
GLOBENEWSWIRE
Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharma
06 Feb 2020 //
GLOBENEWSWIRE
Union Quimico Farmaceutica Fails EDQM Inspection
29 Oct 2019 //
EDQM
Beset by lawsuits and criticism in U.S., opioid makers eye new market in India
31 Aug 2019 //
FIERCE PHARMA
Johnson & Johnson opioid trial judge expected to issue landmark verdict Monday
23 Aug 2019 //
CNBC
Nucynta® (tapentadol): Purdue Pharma v. Collegium NF
07 Feb 2018 //
PATENT LITIGATION
Troubled Depomed sells off Nucynta, axes 40% of workforce
05 Dec 2017 //
FIERCE PHARMA
Depomed wins Nucynta patent fight, but does that harm or help in proxy battle?
03 Sep 2016 //
FIERCE PHARMA
Depomed Announces Patent Trial and Appeal Board Denial of Inter Partes Review
18 Jul 2016 //
PR NEWSWIRE
Did Depomed’s Citizen Petition for Nucynta ER Strategically Backfire?
05 May 2016 //
TWOFOUR INSIGHT
Grunenthal Denied Indian Patent Use of Tapentadol to Treat Osteoarthritis Pain
27 Jan 2016 //
TWOFOUR INSIGHT
Depomed isn`t anti-takeover, CEO says. It was just anti-Horizon
13 Jan 2016 //
FIERCE PHARMA
Horizon drops hostile takeover attack on Depomed after legal ruling
20 Nov 2015 //
FIERCE PHARMA
Depomed Acquires U.S. Rights, First-in-Class Pain Product from Grunenthal
17 Nov 2015 //
PR NEWSWIRE
Depomed`s staffed-up Nucynta salesforce starts bringing home the bacon
16 Nov 2015 //
FIERCE PHARMA MARKETING
Depomed Issues Statement on Horizon Pharma plc`s Unsolicited Exchange Offer
08 Sep 2015 //
PR NEWS WIRE
Actavis` Generic Tapentadol Receives Tentative Approval in US For Pain
20 May 2015 //
FDA
J&J s Pain Drug is Depomed s Gain in 1 05 Billion Deal
16 Jan 2015 //
BLOOMBERG
Shire CEO Extends Deal Drive with $5.2B NPS Pharma Buyout
11 Jan 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.